The Front Room — a clinical regulatory commons
RSS
← Back to feed

Neffy label updated to remove age restriction

Sponsor
ARS Pharmaceuticals $SPRY
Drug
Neffy · epinephrine
Indication
allergic reactions
More on ARS Pharmaceuticals Google News

FDA approved removal of the age requirement from the Neffy (epinephrine nasal spray) label, expanding its use across all age groups.

What this means

Neffy is a nasal spray version of epinephrine, a hormone that quickly reverses severe allergic reactions by opening airways and raising blood pressure. Today FDA removed the age restriction from Neffy's label, allowing its use in both children and adults. This change could make the spray a more convenient emergency option for families managing severe allergies across all ages.

Read original at accessdata.fda.gov
Topic label update